La sclérose systémique (ScS) est une maladie auto-immune dévastatrice d'étiologie inconnue. Le dysfonctionnement immunitaire, la fibrose et la vasculopathie sont les trois principales caractéristiques de cette maladie. Une récente étude a révélé un nouveau lien entre l'auto-immunité et la fibrose, par la présence d'auto-anticorps stimulant le récepteur du facteur de croissance dérivé des plaquettes (PDGFR) des fibroblastes. Ces auto-anticorps sont capables de stimuler les espèces réactives de l'oxygène et d’activer la kinase régulée par un signal extracellulaire (ERK1/2). L’hypothèse que nous formulons est que les cellules musculaires lisses vasculaires (VSMCs) exprimant conjointement les PDGFR, répondront elles aussi aux autoanticorps anti-PDGF-R. Le travail présenté ici vise à valider la présence d'auto-anticorps PDGFR dans les sérums de patients ScS, et à caractériser ensuite la réponse de VSMCs exposées à de l'immunoglobuline G (IgG) de ces sérums, en mesurant l’activation des cascades de signalisation spécifiques, ainsi que l'induction des gènes impliqués dans la réponse fibrotique. Nos résultats démontrent la présence d'une fraction IgG stimulant une réponse phénotypique dans les cultures de VSMCs. Notamment, d’importantes régulations positive et négative des gènes pro-fibrotiques tgfb1 et tgfb2 respectivement, ont été observées dans les VSMCs exposées à des fractions de ScS-IgG. Les fractions de IgG positives pour l'activation de ERK étaient présentes dans la plupart, mais pas dans tous les échantillons de SSc (68%, 19/28), et moins présentes dans les contrôles 27% (11/3). Bien que, les fractions de SSc-IgG ont pu considérablement immunoprécipiter le PDGFR, l'utilisation d'un inhibiteur spécifique des récepteurs au PDGF (AG1296), n'a pas inhibé l'activation de ERK médiée par les fractions de SSc-IgG. Globalement, nos résultats indiquent la présence d'autoanticorps stimulants avec activité pro-fibrotique dans les sérums des patients ScS. Des travaux sont en cours pour identifier l'entité moléculaire responsable de la réponse d’IgG observée dans les cultures de VSMCs. / Systemic Sclerosis (SSc) is a devastating autoimmune disease of unknown etiology. Immune dysfunction, fibrosis and vasculopathy are the three major features of the disease; however, the interactions between these components are poorly understood. A novel link between autoimmunity and fibrosis has been proposed by the presence of stimulatory autoantibodies to the platelet-derived growth factor receptor (PDGFR) on fibroblasts. These autoantibodies were capable of stimulating reactive oxygen species and subsequent activation of ERK1/2. If the anti-PDGFR autoantibodies are present in the systemic circulation of SSc patients, they will most certainly encounter vascular smooth muscle cells (VSMCs). The latter are known to express the PDGFR and response to PDGF, which is a known phenotypic modulator of VSMCs. The work presented here seeks to readdress the presence of stimulatory anti-PDGFR autoantibodies in serum derived from SSc-patients and to characterize the effects of SSc-IgG on VSMCs by measuring the activation of specific signaling cascades and the induction of genes involved in fibrotic responses. Our results demonstrate the presence of an IgG fraction stimulating a phenotypic response in cultured VSMCs. Notably, a significant up-regulation of the pro-fibrotic gene tgfb1 and a significant down-regulation of the anti-fibrotic gene tgfb2 were observed in VSMC exposed to SSc-IgG fractions. Positive IgG fractions for ERK activation were present in most, but not all, SSc samples (68%, 19/28), and they were less present in controls (27%) (3/11). Although, the SSc-IgG fractions were able to significantly immunoprecipitate the PDGFR, the use of a selective PDGFR inhibitor, AG1296, did not inhibit the activation of ERK mediated by SSc-IgG fractions. Altogether, our findings suggest the presence of stimulatory autoantibodies with profibrotic activity in serum derived form SSc patients. Work is in progress to identify the molecular entity responsible for the IgG response observed in cultured VSMCs.

Pulmonary arterial hypertension (PAH) is a rare but fatal disease with an annual mortality rate of 15% despite current therapies. Uncontrolled proliferation of pulmonary artery smooth muscle cells (PASMCs) results in adverse vascular remodeling contributing to PAH. Understanding the mechanisms of PASMC proliferation may identify new targets for treatment. Chloride currents/channels (ICl) are expressed in PASMCs and their roles in proliferation have been suggested based on their importance in resting membrane potential and cell volume regulation. The present study explored the role of ICl in proliferation in rat and human PASMCs. We found that either nonspecific ICl inhibitors (DIDS or NPPB) or a putative specific blocker of swelling-activated ICl (ICl,swell) reduced proliferation of PASMCs cultured in serum-containing media. Patch-clamp studies showed that proliferating PASMCs had increased baseline ICl and ICl,swell in association with depolarized membrane potentials. Quantitative real-time RT-PCR studies identified expressions of CLC-3, a candidate gene of ICl,swell, and several other CLC genes in proliferating PASMCs. While selective knockdown of CLC-3 with lentiviral shRNA reduced PASMC proliferation, it had no effect on ICl,swell. These findings are consistent with the conclusion that ICl regulate proliferation of PASMCs and suggest that selective ICl inhibition may be useful in treating pulmonary arterial hypertension.

An attempt was made to predict the service life of the Black River Bridge using non-linear finite element analysis (NLFEA). Numerical modeling was performed using NLFEA software developed by Prof. Evan Bentz. A large number of analytical studies were conducted to assess the strength and behaviour of the bridge under normal truck loading and at failure loads. It was determined that the bridge is shear critical. Location of trucks that would cause maximum deflection and highest crack widths were identified. It is believed that these findings will have a significant impact on physical measurements that can be incorporated into future bridges, helping researchers determine the locations in the bridge that are ideal for instrumentation. Axial compression present in the bridge can significantly affect deflection and crack widths. Incorporating thermal and shrinkage effects into the NLFEA are recommended as topics for further research. Appropriate estimate of thermal and shrinkage strain will aid in better prediction of axial stresses.

This thesis, “Empirical Asset Pricing and Investment Strategies”, examines a number of topics related to portfolio choice, asset pricing, and strategic and tactical asset allocation. The first two papers treat the predictability of asset returns. Since at least the mid-1980s until quite recently, the conventional wisdom has been that it is possible to predict the return on, for example, an index of stocks. However, a series of recent papers have challenged this conventional wisdom. I answer this challenge and show that it is possible to predict returns if structural changes in the underlying economy are taken into account. The third paper examines the comovement between stocks and bonds. I show how it is possible to improve the composition of a portfolio consisting of these two asset classes by taking into account how the comovement changes over time. All three papers are self-contained and can therefore be read in any order. The first paper is entitled “Structural Breaks in Asset Return Predictability: Can They Be Explained?” Here I investigate whether predictability has changed over time and, if so, whether it is possible to tie the change to any underlying economic variables. Dividend yield and the short interest rate are often used jointly as instruments to predict the return on stocks, but several researchers present evidence that the relation has undergone a structural break. I use a model that extends the conventional structural breaks models to allow both for smooth transitions from one state to another (with a break as a special case), and for transitions that depend on a state variable other than time. The latter allows me to directly test whether, for example, the business cycle influences how the instruments predict returns. The results suggest that this is not the case. However, I do find evidence of a structural change primarily in how the instruments predict returns for large firms. The change differs from a break in that it appears to be an extended non-linear transition during the period 1993—1997. After the change, the short rate does not predict returns at all. Dividend yield, on the other hand, is strongly significant, and the return has become more sensitive to it. In the second paper, “Restoring the Predictability of Equity Returns,” I take another perspective on predictability and structural shifts. Several recent papers have questioned the predictability of equity returns, potentially implying serious negative consequences for investment decision-making. With return data including the 1990s, variables that previously predicted returns, such as the dividend yield, are no longer significant and results of out-of-sample tests are often weak. A possible reason is that the underlying structure of the economy has changed. I use an econometric model that allows for regime shifts over time as well as due to changes in a state variable, in this case the price-earnings ratio. This makes it possible to separate influences from these two sources and to determine whether one or both sources have affected return predictability. The results indicate that, first, a structural change occurred during the 1990s, and, second, that the unusually high level of price earnings in the late 1990s and early 2000s temporarily affected predictability at the 12-month horizon. In the third paper, “Coupling and Decoupling: Changing Relations between Stock and Bond Market Returns,” I investigate stock-bond comovement. The correlation between stocks and bonds has changed dramatically over the last ten years, introducing a new type of risk for portfolio managers, namely, correlation risk. I use GARCH estimates of stock volatility, simple regressions, and regime-switching econometric models to assess whether level of volatility, or changes in volatility, can be used to explain some of the changes in comovement in seven different countries. As regards volatility level, strong support is found in almost all countries to suggest that high volatility predicts lower, or negative, comovement. I argue that this can be evidence of a market-timing type of behavior. As for changes in volatility, the results are more mixed. Only for the U.S. market do I find strong support to conclude that large changes tend to coincide with lower, or negative, comovement. This could be evidence of a flight-to-quality (or cross-market hedging) type of behavior. / <p>Diss. Stockholm : Handelshögskolan, 2007</p>

Boom and bust cycles are widely documented in the literature on industry dynamics. Rigidities and delays in capacity adjustment in combination with bounded rational behavior have been identified as central driving forces. We construct a model that features only these two elements and we show that this is indeed sufficient to reproduce some stylized facts of a boom and bust cycle. The bifurcation diagrams summarizing the dynamic behavior reveal complex cycles and in particular also abrupt changes in the nature of these cycles. We apply new insights from the mathematical theory of piecewise smooth dynamic systems - in particular, results from the theory of border collision bifurcations - and show that the very existence of borders such as capacity constraints or nonnegativity constraints may lie behind abrupt changes in the dynamic behavior of economic variables. (author's abstract) / Series: Department of Economics Working Paper Series

Immunopathological disorders are no longer defined by dysregulated T-helper (Th) type 1/ Th2 responses but account for modulatory cell types such as regulatory and Th17 cells. The newly defined Th17 subset is an effector memory subtype which regulates mucosal host defense responses. A distinctive feature of interleukin (IL)-17 is its ability to invoke neutrophilic responses and to synergize cytokine responses in proximal structural cells. This effect is most evident for proinflammatory cytokines and neutrophil-mobilizing chemokines which are under the regulatory control of the canonical, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. The uniqueness of the IL-17A receptor (IL-17RA) signal transduction pathway however has been a limiting factor in uncovering IL-17-mediated effector functions since the receptor bears little homology to other known receptors and contains a unique cytoplasmic consensus binding motif. Hence, the composition, dynamics and subunit interactions of the IL-17R complex have become an emerging area of research where novel recruitment motifs and adaptor proteins are actively being explored. Our study sought to uncover the signal transduction and molecular mechanisms mediating the initiation and amplification responses induced by IL-17. We hypothesize that (i) IL-17 represents a key cytokine which initiates inflammatory responses by acting on proximal structural cells to rapidly release neutrophil-mobilizing chemokines and myeloid growth factors and that (ii) IL-17 directly promotes survival responses of immune effector cells. Genomic analysis of stimulated human airway smooth muscle cells support the proinflammatory nature of IL-17 as NF-κB associated genes and chemokines were most significantly upregulated within 2 hours. However, IL-17 induced a modest fold increase in gene expression levels whereby only 4 genes achieved greater than 2 fold increases. This, along with the observation that IL-17 enhanced IL-1β-mediated CXCL8 expression via transcriptional promoter activation levels and post-transcriptional mRNA stabilization mechanisms suggests that IL-17 cooperatively functions with secondary cytokines to mediate inflammatory responses. Despite activating the p38-mitogen-activated protein kinase (MAPK) signaling pathway in peripheral blood neutrophils, IL-17 did not directly affect the apoptotic capacity of these cells but unexpectedly antagonized the survival response mediated by the granulocyte-macrophage colony stimulating factor (GM-CSF). Collectively, our results suggest that IL-17 is a potent synergistic cytokine which signals via the MAPK-NF-κB pathway to indirectly recruit neutrophils via CXC-chemokines produced by non-hematopoietic cells and that IL-17 may potentially dampen inflammatory responses by directly antagonizing inflammatory effector cells.

Il a été démontré que les chevaux atteints du souffle présentent une augmentation de la masse de muscle lisse entourant les voies respiratoires comparativement à des chevaux sains (Herszberg, Ramos-Barbon et al. 2006, Leclere, Lavoie-Lamoureux et al. 2011). L’augmentation de la masse de muscle lisse ainsi observée résulte d’une hyperplasie, et possiblement, d’une hypertrophie des myocytes. Les traitements usuels du souffle ne sont que partiellement efficaces à diminuer cette augmentation. L’objectif de cette étude était d’explorer les mécanismes moléculaires impliqués dans ces changements affectant la cellule musculaire lisse dans la pathologie du souffle chez le cheval. Pour ce faire, nous avons examiné les effets d’une exposition antigénique sur l’expression du «Serum Response Factor» (SRF) dans le muscle lisse bronchique. Le SRF est un facteur de transcription localisé dans le noyau de la cellule musculaire lisse et régulant l’expression génique de celle-ci en favorisant un phénotype prolifératif ou contractile. Les résultats démontrent qu’avant exposition antigénique, les pourcentages de cellules exprimant le SRF sont faibles. Une augmentation significative du pourcentage de myocytes exprimant le SRF survient suite à une stimulation antigénique chez les chevaux atteints de souffle alors qu’aucune augmentation n’est observée chez les chevaux contrôles. Ces résultats suggèrent que le SRF pourrait contribuer au remodelage du muscle lisse péribronchique dans la pathologie du souffle. / Previous studies have shown that heaves-affected horses, when compared to age-matched control horses, have an increased smooth muscle mass surrounding their airways (Herszberg, Ramos-Barbon et al. 2006, Leclere, Lavoie-Lamoureux et al. 2011). Also, it is shown that hyperplasia, and possibly hypertrophy, contribute to this finding. Current therapies are only partially effective at reversing this finding. The goal of this study was to explore the molecular pathways involved in airway smooth muscle remodelling during heaves. We studied the Serum Response Factor (SRF), a nuclear transcriptional factor that controls gene expression in the smooth muscle cell and favour either a proliferative or a contractile phenotype. The results show that before antigenic exposition, the percentage of cells expressing SRF is low. A significant increase in the percentage of SRF-expressing myocytes occurs after antigenic stimulation in heaves-affected horses whereas no increase is observed in control subjects. These results suggest that the transcription factor SRF may contribute to airway smooth muscle remodeling in heaves-affected horses.

Understanding the bearing response of the footings on layered soils has always been a challenge for researchers. Due to the limitations of analytical and empirical solutions it had been difficult to understand the true bearing behavior. Some researchers have tried solving this problem by numerical analysis and have found some success. In this study the numerical analysis approach has been applied using a commercial tool FLAC (Fast Lagrangian Analysis of Continua) to study the bearing response of surface footings on layered clays. First, small deformation analyses were taken up to study the undrained bearing response of strip and circular footings resting on a horizontally layered strong over a soft clay foundation, and then over soft over strong clay foundation. In the end application of large strain mode of FLAC was explored to investigate the large deformation behavior of the strip footing resting on the surface of a strong over soft clay foundation. All models were run by applying velocity loading and a elastic-perfectly plastic Tresca yield criterion has been used. The results are compared with published Finite Element Method (FEM) results, and with analytical, empirical and semi-empirical solutions. It was found that bearing capacity results from the present small-strain FLAC analyses agree well with the FEM results. However, these results in most of the cases tend to differ (as much as 49% for certain layered clay foundations) from those predicted with analytical, empirical and semi-empirical solutions, mainly due to the assumptions made in these solutions. Since no such assumptions are made in the present FLAC analyses, the results and the methodology of this thesis can be applied to predict the bearing capacity of the practical problems. Application of the large-strain mode of FLAC to study the large deformation of shallow foundations has pointed out a limitation of FLAC in completing such analyses. However, it is observed from the early trends of these analyses that whereas the small deformation analysis may under estimate the ultimate bearing capacity for certain cases of layered foundations where the upper clay is moderately stiffer than the lower clay layer, it might also over predict the ultimate bearing capacity for other cases when the upper clay is very stiff in comparison to the lower clay layer.

Immunopathological disorders are no longer defined by dysregulated T-helper (Th) type 1/ Th2 responses but account for modulatory cell types such as regulatory and Th17 cells. The newly defined Th17 subset is an effector memory subtype which regulates mucosal host defense responses. A distinctive feature of interleukin (IL)-17 is its ability to invoke neutrophilic responses and to synergize cytokine responses in proximal structural cells. This effect is most evident for proinflammatory cytokines and neutrophil-mobilizing chemokines which are under the regulatory control of the canonical, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. The uniqueness of the IL-17A receptor (IL-17RA) signal transduction pathway however has been a limiting factor in uncovering IL-17-mediated effector functions since the receptor bears little homology to other known receptors and contains a unique cytoplasmic consensus binding motif. Hence, the composition, dynamics and subunit interactions of the IL-17R complex have become an emerging area of research where novel recruitment motifs and adaptor proteins are actively being explored. Our study sought to uncover the signal transduction and molecular mechanisms mediating the initiation and amplification responses induced by IL-17. We hypothesize that (i) IL-17 represents a key cytokine which initiates inflammatory responses by acting on proximal structural cells to rapidly release neutrophil-mobilizing chemokines and myeloid growth factors and that (ii) IL-17 directly promotes survival responses of immune effector cells. Genomic analysis of stimulated human airway smooth muscle cells support the proinflammatory nature of IL-17 as NF-κB associated genes and chemokines were most significantly upregulated within 2 hours. However, IL-17 induced a modest fold increase in gene expression levels whereby only 4 genes achieved greater than 2 fold increases. This, along with the observation that IL-17 enhanced IL-1β-mediated CXCL8 expression via transcriptional promoter activation levels and post-transcriptional mRNA stabilization mechanisms suggests that IL-17 cooperatively functions with secondary cytokines to mediate inflammatory responses. Despite activating the p38-mitogen-activated protein kinase (MAPK) signaling pathway in peripheral blood neutrophils, IL-17 did not directly affect the apoptotic capacity of these cells but unexpectedly antagonized the survival response mediated by the granulocyte-macrophage colony stimulating factor (GM-CSF). Collectively, our results suggest that IL-17 is a potent synergistic cytokine which signals via the MAPK-NF-κB pathway to indirectly recruit neutrophils via CXC-chemokines produced by non-hematopoietic cells and that IL-17 may potentially dampen inflammatory responses by directly antagonizing inflammatory effector cells.

Šio eksperimentinio darbo tikslas buvo įvertinti 1,4-dihidropiridino ir benzimidazolo junginių poveikį jūros kiaulyčių širdies papiliarinių raumenų izometrinei funkcijai bei žmogaus kraujagyslių segmentų susitraukimui ir atsipalaidavimui. Buvo atlikti eksperimentiniai tyrimai su izoliuotais jūros kiaulyčių širdies papiliarinių raumenų preparatais ir izoliuotais žmogaus v.saphena magna ir a.thoracica interna kraujagyslių segmentais. Kraujagyslių preparatai gauti iš pacientų, kuriems buvo atliekamos širdies vainikinių arterijų jungčių suformavimo operacijos LSMU ligoninės Kauno klinikos Kardiochirurgijos klinikoje. Žmogaus izoliuotų kraujagyslių preparatų tyrimams išduotas Kauno regioninio bioetikos komiteto leidimas Nr. BE–2–64, data 2010–11–05. Buvo tiriamas 1,4-dihidropiridinų bei benzimidazolo junginių poveikis izometrinei jūros kiaulyčių širdies papiliarinių raumenų funkcijai, registruojant preparatų elektromechaninį susitraukimo jėgos ir transmembraninio veikimo potencialus. Eksperimentiniai tyrimai, atlikti in vitro sąlygomis, įvertinant 1,4-dihidropiridinų bei benzimidazolo junginių poveikį žmogaus izoliuotų kraujagyslių (v.saphena magna ir a.thoracica interna) segmentų susitraukimui ir atsipalaidavimui, skirtingų ekstraląstelinio Ca2+ koncentracijų įtaką tiriamųjų junginių poveikiui kraujagyslių segmentų susitraukimui ir atsipalaidavimui. Tiriamieji 1,4–dihidropiridinų junginiai sintezuoti Latvijos Organinės Sintezės institute. / This study aim was to evaluate the effects of 1,4-dihydropiridines and benzimidazole deriva¬tives on the isometric function of guinea pig papillary cardiac muscles and the contraction and relaxation of vascular segments in humans. The experiments were carried out on isolated samples of human great saphenous vein (v. saphena magna) and internal thoracic artery (a. tho¬racica interna). The vein and arteries samples were taken from patients who underwent coronary artery bypass. The study was approved by the Regional Ethics Committee of the Biomedical Research on 05/11/2010, license No. BE-2-64, Kaunas, Lithuania. The inotropic activity and transmembrane AP duration of the dihydropyridine derivatives were evaluated on the guinea-pig papillary muscles and aorta vascular samples. Synthesis of 1,4-dihydropyridine derivatives were performed in Latvian Organic Synthesis institute. During this study were performed the evaluation of 1,4-dihydropyridines and benzimidazole derivatives on contraction force and action potential in guinea pig papillary muscles. Effects of 1,4-dihydropyridines and benzimidazole derivatives on contraction and relaxation of the segments of the great sa¬phenous vein (v. saphena magna) and internal thoracic artery (a. tho¬racica interna) in humans, the extra-cellular concentration of Ca2+ and the effect of the studied compounds and were evaluated. Also assessment of preventive effect of the calcium channel blockers and benzimidazole derivative on contraction... [to full text]